CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

No association between the IL28B SNP and response to peginterferon plus ribavirin combination treatment in Korean chronic hepatitis C patients

Nae-Yun Heo, Young-Suk Lim, Woochang Lee, Minkyung Oh, Jiyun An, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Han Chu Lee, Yung Sang Lee, Dong Jin Suh

Clin Mol Hepatol. 2014;20(2):177-184. Published online 2014 June 30 DOI: https://doi.org/10.3350/cmh.2014.20.2.177

No association between the IL28B SNP and response to peginterferon plus ribavirin combination treatment in Korean chronic hepatitis C patients

Nae-Yun Heo, Young-Suk Lim, Woochang Lee, Minkyung Oh, Jiyun An, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Han Chu Lee, Yung Sang Lee, Dong Jin Suh

Clinical and Molecular Hepatology. 2014;20(2):177

Link1 Link2 Link3

Treatment of chronic hepatitis C: Efficacy of initial treatment of peginterferon alpha-2a versus peginterferon alpha-2b plus ribavirin in naive chronic hepatitis C patients

Youn Jae Lee

The Korean Journal of Hepatology. 2008;14(4):443

Link1 Link2 Link3

Comparison of therapeutic results between combination therapy of peginterferon alpha-2a plus ribavirin and interferon alpha-2b plus ribavirin according to treatment duration in patients with chronic hepatitis C

Heon Ju Lee, Jong Ryul Eun, Jae Won Choi, Kyung Ok Kim, Hee Jung Moon

The Korean Journal of Hepatology. 2008;14(1):46

Link1 Link2 Link3

Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C

A. M. Di Bisceglie, R. H. Ghalib, F. M. Hamzeh, V. K. Rustgi

Journal of Viral Hepatitis. 2007;070701233506001-???

Link1 Link2

Factors responsible for the discrepancy betweenIL28Bpolymorphism prediction and the viral response to peginterferon plus ribavirin therapy in Japanese chronic hepatitis C patients

Hiroaki Saito, Kiyoaki Ito, Masaya Sugiyama, Teppei Matsui, Yoshihiko Aoki, Masatoshi Imamura, Kazumoto Murata, Naohiko Masaki, Hideyuki Nomura, Hiroshi Adachi, Shuhei Hige, Nobuyuki Enomoto, Naoya Sakamoto, Masayuki Kurosaki, Masashi Mizokami, Sumio Watanabe

Hepatology Research. 2012;42(10):958-965

Link1

Sa1055 IL28B Polymorphism is Associated With Liver Steatosis and Treatment Response to PEG-Interferon Plus Ribavirin Combination Therapy, but is Not Associated With Hepatocarcinogenesis in Patients With Chronic Hepatitis C

Hidemi Goto, Kazuhiko Hayashi, Yoshihiko Tachi

Gastroenterology. 2012;142(5):S-957

Link1 Link2

Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C

G Davis

Hepatology. 2003;38(3):645-652

Link1 Link2

PGI24 Cost Effectiveness of the Combination of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Peginterferon Alfa Plus Ribavirin in the Retreatment of Patients with Chronic Hepatitis C Virus Genotype I Infection

M. Fonseca, G. Tannus, E. Parisi

Value in Health. 2012;15(4):A139

Link1 Link2

PGI21 Cost Effectiveness of the Combination of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Telaprevir Plus Peginterferon Alfa and Ribavirin in the Retreatment of Patients With Chronic Hepatitis C Virus Genotype I Infection

M. Fonseca, V. Garran, G.T. Araujo

Value in Health. 2012;15(7):A329

Link1 Link2

PGI25 Cost Effectiveness of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Peginterferon Alfa Plus Ribavirin in the Treatment of Chronic Hepatitis C (CHC) in Previously Untreated Genotype I Patients

M. Fonseca, G. Tannus, E. Parisi

Value in Health. 2012;15(4):A139

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.